Scar extent evaluated by late gadolinium enhancement CMR: A powerful predictor of long term appropriate ICD therapy in patients with coronary artery disease

Journal of Cardiovascular Magnetic Resonance

Volumn 15, Issue 1, 2013, Pages

  Alexandre, Joachim ^a   Saloux, Eric ^a,b   Dugué, Audrey Emmanuelle ^a,b   Lebon, Alain ^a,b   Lemaitre, Adrien ^a   Roule, Vincent ^a,b   Labombarda, Fabien ^a   Provost, Nicole ^a   Gomes, Sophie ^a   Scanu, Patrice ^a   Milliez, Paul ^a,b  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE CAEN   (France)

Author keywords

Cardiovascular magnetic resonance; Coronary artery disease; Implantable cardioverter defibrillator; Scar tissue; Sudden cardiac death; Ventricular arrhythmias

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; AMIODARONE; ANGIOTENSIN II ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GADOLINIUM; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARDIOVASCULAR MAGNETIC RESONANCE; CORONARY ARTERY DISEASE; DEVICE THERAPY; FEMALE; FOLLOW UP; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTATION; LATE GADOLINIUM ENHANCEMENT CARDIOVASCULAR MAGNETIC RESONANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVASCULARIZATION; RISK; SCAR;

AGED; ARRHYTHMIAS, CARDIAC; CONTRAST MEDIA; CORONARY ARTERY DISEASE; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MAGNETIC RESONANCE IMAGING, CINE; MALE; MEGLUMINE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIUM; ORGANOMETALLIC COMPOUNDS; PREDICTIVE VALUE OF TESTS; PRIMARY PREVENTION; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SECONDARY PREVENTION; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84872343453     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-15-12     Document Type: Article

References (37)

1. Sudden cardiac death. Zipes DP, Wellens HJ, Circulation 1998 98 2334 2351 10.1161/01.CIR.98.21.2334 9826323 (Pubitemid 28533855)
2. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NAM 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Faxon DP, Halperin JL, Hiratzka LF, Hunt SA, Krumholz HM, Kushner FG, Circulation 2008 117 350 e408 18483207
3. Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study. Buxton AE, Lee KL, Hafley GE, Pires LA, Fisher JD, Gold MR, Josephson ME, Lehmann MH, Prystowsky EN, J Am Coll Cardiol 2007 50 1150 1157 10.1016/j.jacc.2007.04.095 17868806 (Pubitemid 47375017)
4. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Moss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW, Daubert JP, McNitt S, Andrews ML, Elkin AD, Circulation 2004 110 3760 3765 10.1161/01.CIR.0000150390.04704.B7 15583079 (Pubitemid 40023973)
5. Electrophysiologic substrate underlying postinfarction ventricular tachycardia: characterization and role in catheter ablation. Haqqani HM, Marchlinski FE, Heart Rhythm 2009 6 70 S76 10.1016/j.hrthm.2009.04.023 19631910
6. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ, Lancet 2001 357 21 28 10.1016/S0140-6736(00)03567-4 11197356 (Pubitemid 32056497)
7. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM, Circulation 1999 100 1992 2002 10.1161/01.CIR.100.19.1992 10556226 (Pubitemid 29529292)
8. Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study. Wu E, Ortiz JT, Tejedor P, Lee DC, Bucciarelli-Ducci C, Kansal P, Carr JC, Holly TA, Lloyd-Jones D, Klocke FJ, Bonow RO, Heart 2008 94 730 736 10.1136/hrt.2007.122622 18070953 (Pubitemid 351744690)
9. Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study. Kwon DH, Halley CM, Carrigan TP, Zysek V, Popovic ZB, Setser R, Schoenhagen P, Starling RC, Flamm SD, Desai MY, JACC Cardiovasc Imaging 2009 2 34 44 10.1016/j.jcmg.2008.09.010 19356530
10. Scar size and characteristics assessed by CMR predict ventricular arrhythmias in ischaemic cardiomyopathy: comparison of previously validated models. de Haan S, Meijers TA, Knaapen P, Beek AM, van Rossum AC, Allaart CP, Heart 2011 97 1951 1956 10.1136/heartjnl-2011-300060 21917670
11. The extent of left ventricular scar quantified by late gadolinium enhancement MRI is associated with spontaneous ventricular arrhythmias in patients with coronary artery disease and implantable cardioverter- defibrillators. Scott PA, Morgan JM, Carroll N, Murday DC, Roberts PR, Peebles CR, Harden SP, Curzen NP, Circ Arrhythm Electrophysiol 2011 4 324 330 10.1161/CIRCEP.110.959544 21493964
12. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator. Roes SD, Borleffs CJW, van der Geest RJ, Westenberg JJM, Marsan NA, Kaandorp TAM, Reiber JHC, Zeppenfeld K, Lamb HJ, de Roos A, Schalij MJ, Bax JJ, Circ Cardiovasc Imaging 2009 2 183 190 10.1161/CIRCIMAGING.108.826529 19808591
13. Quantitative characterization of myocardial infarction by cardiovascular magnetic resonance predicts future cardiovascular events in patients with ischemic cardiomyopathy. Yokota H, Heidary S, Katikireddy CK, Nguyen P, Pauly JM, McConnell MV, Yang PC, J Cardiovasc Magn Reson 2008 10 17 10.1186/1532-429X-10-17 18400089
14. Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Hombach V, Grebe O, Merkle N, Waldenmaier S, Höher M, Kochs M, Wöhrle J, Kestler HA, Eur Heart J 2005 26 549 557 15713695 (Pubitemid 40461096)
15. Design and validation of Segment-freely available software for cardiovascular image analysis. Heiberg E, Sjögren J, Ugander M, Carlsson M, Engblom H, Arheden H, BMC Med Imaging 2010 10 1 10.1186/1471-2342-10-1 20064248
16. Semi-automatic quantification of myocardial infarction from delayed contrast enhanced magnetic resonance imaging. Heiberg E, Engblom H, Engvall J, Hedström E, Ugander M, Arheden H, Scand Cardiovasc J 2005 39 267 275 10.1080/14017430500340543 16269396 (Pubitemid 43203068)
17. Automated quantification of myocardial infarction from MR images by accounting for partial volume effects: animal, phantom, and human study. Heiberg E, Ugander M, Engblom H, Götberg M, Olivecrona GK, Erlinge D, Arheden H, Radiology 2008 246 2 581 588 18055873
18. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS, Int J Cardiovasc Imaging 2002 18 539 542 12135124 (Pubitemid 34262671)
19. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC Jr, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc J-J, Budaj A, Camm AJ, J Am Coll Cardiol 2006 48 247 e346 10.1016/j.jacc.2006.07.010 16949478 (Pubitemid 44382683)
20. Patient selection for cardiac resynchronization therapy: from the Council on Clinical Cardiology Subcommittee on Electrocardiography and Arrhythmias and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society. Strickberger SA, Conti J, Daoud EG, Havranek E, Mehra MR, Piña IL, Young J, Circulation 2005 111 2146 2150 10.1161/01.CIR.0000161276.09685.4A 15851622 (Pubitemid 40577912)
21. Sudden death due to cardiac arrhythmias. Huikuri HV, Castellanos A, Myerburg RJ, N Engl J Med 2001 345 1473 1482 10.1056/NEJMra000650 11794197
22. Time dependence of life-threatening ventricular tachyarrhythmias after coronary revascularization in MADIT-CRT. Barsheshet A, Goldenberg I, Narins CR, Moss AJ, McNitt S, Wang PJ, Huang DT, Hall WJ, Zareba W, Eldar M, Guetta V, Heart Rhythm 2010 7 1421 1427 10.1016/j.hrthm.2010.07.005 20620231
23. Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation. de Bakker JM, van Capelle FJ, Janse MJ, Wilde AA, Coronel R, Becker AE, Dingemans KP, van Hemel NM, Hauer RN, Circulation 1988 77 589 606 10.1161/01.CIR.77.3.589 3342490 (Pubitemid 18073351)
24. Prediction of life-threatening arrhythmic events in patients with chronic myocardial infarction by contrast-enhanced CMR. Boyé P, Abdel-Aty H, Zacharzowsky U, Bohl S, Schwenke C, van der Geest RJ, Dietz R, Schirdewan A, Schulz-Menger J, JACC Cardiovasc Imaging 2011 4 871 879 10.1016/j.jcmg.2011.04. 014 21835379
25. Influence of transmurality, infarct size, and severe microvascular obstruction on left ventricular remodeling and function after primary coronary angioplasty. Tarantini G, Razzolini R, Cacciavillani L, Bilato C, Sarais C, Corbetti F, Marra MP, Napodano M, Ramondo A, Iliceto S, Am J Cardiol 2006 98 1033 1040 10.1016/j.amjcard.2006.05.022 17027566 (Pubitemid 44486139)
26. Angiographic estimates of myocardium at risk during acute myocardial infarction: validation study using cardiac magnetic resonance imaging. Ortiz-Pérez JT, Meyers SN, Lee DC, Kansal P, Klocke FJ, Holly TA, Davidson CJ, Bonow RO, Wu E, Eur Heart J 2007 28 1750 1758 10.1093/eurheartj/ ehm212 17586811 (Pubitemid 47227100)
27. The wavefront phenomenom of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Reimer KA, Jennings RB, Lab Invest 1979 40 633 644 449273 (Pubitemid 9191795)
28. Longitudinal and circumferential strain rate, left ventricular remodeling, and prognosis after myocardial infarction. Hung CL, Verma A, Uno H, Shin SH, Bourgoun M, Hassanein AH, McMurray JJ, Velazquez EJ, Kober L, Pfeffer MA, Solomon SD, VALIANT investigators, J Am Coll Cardiol 2010 56 1812 1822 10.1016/j.jacc.2010.06.044 21087709
29. Cardiovascular magnetic resonance of the myocardium at risk in acute reperfused myocardial infarction: comparison of T2-weighted imaging versus the circumferential endocardial extent of late gadolinium enhancement with transmural projection. Ubachs JF, Engblom H, Erlinge D, Jovinge S, Hedström E, Carlsson M, Arheden H, J Cardiovasc Magn Reson 2010 29 12 18
30. Cellular mechanisms of myocardial infarct expansion. Weisman HF, Bush DE, Mannisi JA, Weisfeldt ML, Healy B, Circulation 1988 78 186 201 10.1161/01.CIR.78.1.186 2968197
31. Factors influencing infarct size following experimental coronary artery occlusions. Maroko PR, Kjekshus JK, Sobel BE, Watanabe T, Covell JW, Ross J, Braunwald E Jr, Circulation 1971 43 67 82 10.1161/01.CIR.43.1.67 5540853
32. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Choi KM, Kim RJ, Gubernikoff G, Vargas JD, Parker M, Judd RM, Circulation 2001 104 1101 1107 10.1161/hc3501.096798 11535563 (Pubitemid 32830391)
33. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Yan AT, Shayne AJ, Brown KA, Gupta SN, Chan CW, Luu TM, Di Carli MF, Reynolds HG, Stevenson WG, Kwong RY, Circulation 2006 114 32 39 10.1161/CIRCULATIONAHA.106.613414 16801462 (Pubitemid 44305272)
34. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Schmidt A, Azevedo CF, Cheng A, Gupta SN, Bluemke DA, Foo TK, Gerstenblith G, Weiss RG, Marbán E, Tomaselli GF, Lima JAC, Wu KC, Circulation 2007 115 2006 2014 10.1161/CIRCULATIONAHA.106.653568 17389270 (Pubitemid 46625951)
35. Myocardial scar extent evaluated by cardiac magnetic resonance imaging in ICD patients: relationship to spontaneous VT during long-term follow-up. Bernhardt P, Stiller S, Kottmair E, Binner L, Spiess J, Grossmann G, Rasche V, Walcher D, Hombach V, Int J Cardiovasc Imaging 2011 27 893 900 10.1007/s10554-010-9726-9 20957518
36. Cardiovascular magnetic resonance characterization of peri-infarct zone remodeling following myocardial infarction. Schuleri KH, Centola M, Evers KS, Zviman A, Evers R, Lima JA, Lardo AC, J Cardiovasc Magn Reson 2012 14 24 10.1186/1532-429X-14-24 22510220
37. Biventricular pacing diminishes the need for implantable cardioverter defibrillator therapy. Ventak CHF Investigators. Higgins SL, Yong P, Sheck D, McDaniel M, Bollinger F, Vadecha M, Desai S, Meyer DB, J Am Coll Cardiol. 2000 36 824 827 10.1016/S0735-1097(00)00795-6 10987605